4 1 form4_11500.txt FORM 4 - RXBAZAAR, INC. ======== FORM 4 ======== U.S. SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940 [X] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). ________________________________________________________________________________ 1. Name and Address of Reporting Person* Able Laboratories, Inc. -------------------------------------------------------------------------------- (Last) (First) (Middle) 6 Hollywood Court -------------------------------------------------------------------------------- (Street) South Plainfield NJ 07080 -------------------------------------------------------------------------------- (City) (State) (Zip) ________________________________________________________________________________ 2. Issuer Name and Ticker or Trading Symbol RxBazaar, Inc. (1) ________________________________________________________________________________ 3. IRS Identification Number of Reporting Person, if an Entity (Voluntary) ________________________________________________________________________________ 4. Statement for Month/Year September 9, 2002 ________________________________________________________________________________ 5. If Amendment, Date of Original (Month/Year) ________________________________________________________________________________ 6. Relationship of Reporting Person (s) to Issuer (Check all applicable) [_] Director [_] 10% Owner [_] Officer (give title below) [X] Other (specify below) Former 10% Owner ________________________________________________________________________________ 7. Individual or Joint/Group Filing (Check applicable line) [X] Form filed by one Reporting Person [_] Form filed by more than one Reporting Person ________________________________________________________________________________ ================================================================================ TABLE I - NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED ================================================================================

(Print or Type Response) (Over) FORM 4 (continued) TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) ================================================================================

Explanation of Responses: (1) Currently, there is no active trading market for the common stock. RxBazaar expects that its common stock will be listed for quotation on the OTC Bulletin Board under a symbol to be assigned by the National Association of Securities Dealers, Inc. (2) Received pursuant to a stock dividend paid on RxBazaar's outstanding Series A Preferred Stock. (3) Able has entered into an agreement with RxBazaar under which it may not convert or exercise any derivative security of RxBazaar if immediately after such conversion or exercise it would beneficially own greater than 4.9% of the issued and outstanding shares of common stock of RxBazaar. (4) Each share of Series A Preferred Stock is convertible into one share of common stock. (5) Estimated. Able has the right to convert the notes at the then current market price of the common stock. Able Laboratories, Inc. /s/ Dhananjay G. Wadekar, President & CEO September 11, 2002 --------------------------------------------- ----------------------- **Signature of Reporting Person Date Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, SEE Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. SEE 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure Page 2

RXBAZAAR INC 4